1. Medtech Insight
  2. >>Geography
  3. >>Europe

MHRA Issues Guidance On Recognizing And Reporting Medtech Software Adverse Events

 
• By Eliza Slawther

When it comes to medtech adverse events incidents may not always be obvious. This is especially the case with medical device software where indirect harm is the most likely outcome of an incident, the UK’s MHRA explains in new guidance.

Medtech App
• Source: Shutterstock

While manufacturers of medical devices will likely be familiar with the reporting of adverse events to regulators that occur after a product is placed on the market, new technologies such as software as a medical device (SaMD) and artificial intelligence as a medical device (AIaMD) may pose new and unexpected risks to patients.

Recent guidance from the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) sets out examples of adverse events that manufacturers...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Europe

Small, Sleek, Ambitious: ViCentra Raises $85M To Develop Kaleido 2 Insulin Pump, Eyes US Market

 
• By Marion Webb

Dutch insulin pump maker ViCentra secured $85m to scale European manufacturing, preparing for the 2026 launch of its thinner, lighter Kaleido 2 pump and push into US market. CEO Tom Arnold said the pump has more than 3,500 users in Europe and expects “tens of thousands” in the next 18 months.

Salient Bio Raises £2.35M For March 2026 Rollout Of At-Home IBD Microbiome Test

 
• By Natasha Barrow

Salient's inflammatory bowel disease test, built on the start-up’s Signal platform, is planned to launch in March 2026. The company leverages rich data from existing wellness tests to develop signatures, focusing on conditions that are often misdiagnosed and disproportionately affect women.

Government-Backed UK Network Enhances Access To Clinical Trials

 
• By Vibha Sharma

The UK government expects that its new nation-wide network will enable companies to set up clinical trials more quickly and expand access to diverse patient populations across the National Health Service.

European Commission Review of the MDR and IVDR – Where Are We Right Now?

 
• By Amanda Maxwell

Political and regulatory pressures make revising the EU’s medtech regulations a tricky balancing act, two renowned medtech experts, Erik Vollebregt and Bassil Akra told Medtech Insight during a recent interview.

More from Geography

‘Serious Flaws’ In Medicare’s Proposal To Restart DME Competitive Bidding, AdvaMed Says

 
• By Brian Bossetta

A proposed rule from Medicare would impact essential devices for many beneficiaries. AdvaMed says the rule would reduce incentives for companies to innovate and criticizes CMS for not providing the necessary information stakeholders need to fully understand the proposal’s implications.

Fairtility’s FDA-Cleared CHLOE Brings AI To Embryo Selection

 
• By Elizabeth Orr

Israeli device firm Fairtility recently obtained US FDA clearance for the CHLOE platform, which uses AI to make embryo assessments performed as part of in vitro fertilization more transparent, efficient and reliable.

Salient Bio Raises £2.35M For March 2026 Rollout Of At-Home IBD Microbiome Test

 
• By Natasha Barrow

Salient's inflammatory bowel disease test, built on the start-up’s Signal platform, is planned to launch in March 2026. The company leverages rich data from existing wellness tests to develop signatures, focusing on conditions that are often misdiagnosed and disproportionately affect women.